P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000969164.32364.1c |
_version_ | 1797280126524719104 |
---|---|
author | Sjoerd Hermans Yvette van Norden Erik van Werkhoven Avinash Dinmohamed Peter Huijgens Gert Ossenkoppele Gerwin Huls Bob Löwenberg Thomas Pabst Dimitri Breems Douwe Postmus Francesco Pignatti Jurjen Versluis Jan Cornelissen |
author_facet | Sjoerd Hermans Yvette van Norden Erik van Werkhoven Avinash Dinmohamed Peter Huijgens Gert Ossenkoppele Gerwin Huls Bob Löwenberg Thomas Pabst Dimitri Breems Douwe Postmus Francesco Pignatti Jurjen Versluis Jan Cornelissen |
author_sort | Sjoerd Hermans |
collection | DOAJ |
first_indexed | 2024-03-07T16:36:42Z |
format | Article |
id | doaj.art-c16caf3ba82a4bbb882f171f37e1d875 |
institution | Directory Open Access Journal |
issn | 2572-9241 |
language | English |
last_indexed | 2024-03-07T16:36:42Z |
publishDate | 2023-08-01 |
publisher | Wiley |
record_format | Article |
series | HemaSphere |
spelling | doaj.art-c16caf3ba82a4bbb882f171f37e1d8752024-03-03T09:43:32ZengWileyHemaSphere2572-92412023-08-017e323641c10.1097/01.HS9.0000969164.32364.1c202308003-00465P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTSSjoerd Hermans0Yvette van Norden1Erik van Werkhoven2Avinash Dinmohamed3Peter Huijgens4Gert Ossenkoppele5Gerwin Huls6Bob Löwenberg7Thomas Pabst8Dimitri Breems9Douwe Postmus10Francesco Pignatti11Jurjen Versluis12Jan Cornelissen131 Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands1 Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands1 Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands3 Netherlands Comprehensive Cancer Organisation (IKNL), Research and Development, Utrecht, The Netherlands3 Netherlands Comprehensive Cancer Organisation (IKNL), Research and Development, Utrecht, The Netherlands4 Amsterdam University Medical Centers, Vrije Universiteit Medical Center, Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands5 University Medical Center Groningen (UMCG), Hematology, Groningen, The Netherlands1 Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands6 Inselspital, Bern University Hospital, Department of Medical Oncology, Bern, Switzerland7 Ziekenhuis Netwerk Antwerpen, Hematology, Antwerpen, Belgium8 University of Groningen, University Medical Center Groningen, Epidemiology, Groningen, The Netherlands9 European Medicines Agency, Oncology and Hematology Office, Amsterdam, The Netherlands1 Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands1 Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlandshttp://journals.lww.com/10.1097/01.HS9.0000969164.32364.1c |
spellingShingle | Sjoerd Hermans Yvette van Norden Erik van Werkhoven Avinash Dinmohamed Peter Huijgens Gert Ossenkoppele Gerwin Huls Bob Löwenberg Thomas Pabst Dimitri Breems Douwe Postmus Francesco Pignatti Jurjen Versluis Jan Cornelissen P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS HemaSphere |
title | P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS |
title_full | P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS |
title_fullStr | P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS |
title_full_unstemmed | P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS |
title_short | P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS |
title_sort | p565 real world data as supplementary controls for the prospective randomized hovon 103 trial in intensively treated elderly acute myeloid leukemia patients |
url | http://journals.lww.com/10.1097/01.HS9.0000969164.32364.1c |
work_keys_str_mv | AT sjoerdhermans p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients AT yvettevannorden p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients AT erikvanwerkhoven p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients AT avinashdinmohamed p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients AT peterhuijgens p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients AT gertossenkoppele p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients AT gerwinhuls p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients AT boblowenberg p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients AT thomaspabst p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients AT dimitribreems p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients AT douwepostmus p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients AT francescopignatti p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients AT jurjenversluis p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients AT jancornelissen p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients |